|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-12-19
|
|
pubmed:abstractText |
Coffee is a rich source of antioxidative polyphenols, but epidemiological studies and interventional trials have failed to demonstrate any clear beneficial effects of coffee consumption on hypertension. The interaction between hydroxyhydroquinone (HHQ) and 5-caffeoylquinic acid (CQA) was examined, in an attempt to understand the controversial effects of coffee on hypertension.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/3-nitrotyrosine,
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholine,
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Chlorogenic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrogen Peroxide,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroquinones,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Nitroprusside,
http://linkedlifedata.com/resource/pubmed/chemical/Quinic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Tyrosine,
http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents,
http://linkedlifedata.com/resource/pubmed/chemical/caffeoylquinic acid,
http://linkedlifedata.com/resource/pubmed/chemical/hydroxyhydroquinone
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0895-7061
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
23-7
|
|
pubmed:dateRevised |
2009-2-24
|
|
pubmed:meshHeading |
pubmed-meshheading:18091740-Acetylcholine,
pubmed-meshheading:18091740-Animals,
pubmed-meshheading:18091740-Antihypertensive Agents,
pubmed-meshheading:18091740-Blood Pressure,
pubmed-meshheading:18091740-Body Weight,
pubmed-meshheading:18091740-Chlorogenic Acid,
pubmed-meshheading:18091740-Disease Models, Animal,
pubmed-meshheading:18091740-Endothelium, Vascular,
pubmed-meshheading:18091740-Heart Rate,
pubmed-meshheading:18091740-Hydrogen Peroxide,
pubmed-meshheading:18091740-Hydroquinones,
pubmed-meshheading:18091740-Hypertension,
pubmed-meshheading:18091740-Immunohistochemistry,
pubmed-meshheading:18091740-Male,
pubmed-meshheading:18091740-Nitric Oxide,
pubmed-meshheading:18091740-Nitroprusside,
pubmed-meshheading:18091740-Quinic Acid,
pubmed-meshheading:18091740-Rats,
pubmed-meshheading:18091740-Rats, Inbred SHR,
pubmed-meshheading:18091740-Rats, Inbred WKY,
pubmed-meshheading:18091740-Time Factors,
pubmed-meshheading:18091740-Tyrosine,
pubmed-meshheading:18091740-Vasodilation,
pubmed-meshheading:18091740-Vasodilator Agents
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Hydroxyhydroquinone interferes with the chlorogenic acid-induced restoration of endothelial function in spontaneously hypertensive rats.
|
|
pubmed:affiliation |
Biological Science Laboratories, Kao Corporation, Tochigi, Japan. suzuki.atsushi2@kao.co.jp
|
|
pubmed:publicationType |
Journal Article
|
